FMI
DGX icon

Fiduciary Management Inc’s Quest Diagnostics DGX Stock Holding History

Fiduciary Management Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141M Sell
720,986
-325,935
-31% -$63.3M 1.75% 25
2025
Q4 		$182M Sell
1,046,921
-100,613
-9% -$18.3M 2% 14
2025
Q3 		$219M Sell
1,147,534
-37,784
-3% -$6.71M 2.21% 8
2025
Q2 		$213M Sell
1,185,318
-66,084
-5% -$11.5M 2.04% 11
2025
Q1 		$212M Sell
1,251,402
-51,298
-4% -$8.43M 2.05% 14
2024
Q4 		$197M Sell
1,302,700
-84,077
-6% -$13.1M 1.83% 19
2024
Q3 		$215M Sell
1,386,777
-39,878
-3% -$5.96M 1.89% 16
2024
Q2 		$195M Sell
1,426,655
-71,954
-5% -$9.85M 1.82% 19
2024
Q1 		$199M Buy
+1,498,609
New +$194M 1.78% 21
2022
Q2 		– Sell
-1,646,275
Closed -$225M – 69
2022
Q1 		$225M Sell
1,646,275
-739,203
-31% -$103M 1.82% 25
2021
Q4 		$413M Sell
2,385,478
-1,000,656
-30% -$152M 3.04% 9
2021
Q3 		$492M Sell
3,386,134
-27,691
-0.8% -$4.05M 3.67% 5
2021
Q2 		$451M Sell
3,413,825
-100,021
-3% -$13.1M 3.31% 7
2021
Q1 		$451M Sell
3,513,846
-120,357
-3% -$14.8M 3.38% 7
2020
Q4 		$433M Sell
3,634,203
-273,146
-7% -$33.3M 3.28% 9
2020
Q3 		$447M Sell
3,907,349
-193,592
-5% -$22.9M 3.69% 5
2020
Q2 		$467M Sell
4,100,941
-557,226
-12% -$59.1M 3.92% 6
2020
Q1 		$374M Buy
4,658,167
+68,125
+1% +$7.05M 3.26% 7
2019
Q4 		$490M Sell
4,590,042
-121,588
-3% -$12.7M 3.04% 10
2019
Q3 		$504M Buy
4,711,630
+322,605
+7% +$33.1M 3.27% 8
2019
Q2 		$447M Buy
4,389,025
+190,511
+5% +$18.3M 2.86% 15
2019
Q1 		$378M Sell
4,198,514
-16,169
-0.4% -$1.4M 2.47% 19
2018
Q4 		$351M Buy
4,214,683
+120,057
+3% +$11.3M 2.5% 15
2018
Q3 		$442M Sell
4,094,626
-144,124
-3% -$15.8M 2.77% 13
2018
Q2 		$466M Buy
4,238,750
+569,035
+16% +$59.3M 2.98% 13
2018
Q1 		$368M Buy
3,669,715
+1,590,069
+76% +$163M 2.25% 20
2017
Q4 		$205M Buy
+2,079,646
New +$197M 1.26% 26

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Fiduciary Management Inc's DGX Position: Q1 2026 in Review

Fiduciary Management Inc reduced its Quest Diagnostics (DGX) stake by 31% in Q1 2026, selling an estimated $63.3M and leaving 720,986 shares worth $141M. The position accounts for 1.75% of the portfolio, ranked #25.

Fiduciary Management Inc first reported a position in DGX in Q4 2017 and has held it in 27 quarters since. The position peaked at $504M in Q3 2019. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Fiduciary Management Inc held 720,986 shares of Quest Diagnostics worth $141M as of Q1 2026.
  • Fiduciary Management Inc sold 325,935 Quest Diagnostics shares in Q1 2026, an estimated $63.3M.
  • Quest Diagnostics made up 1.75% of Fiduciary Management Inc's portfolio in Q1 2026, its #25 holding.
  • Fiduciary Management Inc first reported a position in Quest Diagnostics in Q4 2017 and has held it in 27 quarters since.
  • Fiduciary Management Inc's Quest Diagnostics position peaked at $504M in Q3 2019.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Fiduciary Management Inc's 13F filing for Q1 2026, filed 14 May 2026.